Xu, Ling <br/><br/>
Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.  [electronic resource] 

 -  BMC cancer  Jun 2010 
 - 302 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-10-302  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Bile Duct Neoplasms--genetics<br/>Bile Ducts, Intrahepatic--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cetuximab<br/>Cholangiocarcinoma--genetics<br/>Dose-Response Relationship, Drug<br/>ErbB Receptors--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Mutation<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-met--metabolism<br/>Proto-Oncogene Proteins p21(ras)<br/>RNA, Messenger--metabolism<br/>Receptors, Growth Factor--metabolism<br/>Receptors, Somatomedin--metabolism<br/>Receptors, Vascular Endothelial Growth Factor--metabolism<br/>Time Factors<br/>ras Proteins--genetics